O. Aravena

发表

Multiple imputation procedures allow the rescue of missing data: an application to determine serum tumor necrosis factor (TNF) concentration values during the treatment of rheumatoid arthritis patients with anti-TNF therapy.

R. Villegas, J. Cuenca, J. Aguillón, 2005, Biological research.

Inflammation, synovial angiogenesis and chondroid apoptosis in the evolution of type II collagen-induced arthritis.

J. Aguillón, B. Pesce, L. Salazar, 2007, European cytokine network.

TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients

M. Menon, J. Aguillón, C. Mauri, 2017, Arthritis Research & Therapy.

The -308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene and ex vivo lipopolysaccharide-induced TNF-alpha expression in patients with aggressive periodontitis and/or type 1 diabetes mellitus.

J. Cuenca, A. Aguirre, Arturo Ferreira, 2004, European cytokine network.

Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells.

P. Lastres, J. Aguillón, N. Dutzan, 2008, Journal of clinical periodontology.

Regulation of Tolerogenic Features on Dexamethasone-Modulated MPLA-Activated Dendritic Cells by MYC

Ahmed M. Mehdi, M. Molina, J. Aguillón, 2019, Front. Immunol..

Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells

R. Toes, A. Aguirre, A. Escobar, 2007, Annals of the rheumatic diseases.

Short-term lipopolysaccharide stimulation induces differentiation of murine bone marrow-derived dendritic cells into a tolerogenic phenotype.

J. Aguillón, A. Kalergis, M. Iruretagoyena, 2007, European cytokine network.

Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis.

J. Aguillón, B. Pesce, H. Gatica, 2008, Clinical and experimental rheumatology.

Blocking of p38 and transforming growth factor β receptor pathways impairs the ability of tolerogenic dendritic cells to suppress murine arthritis.

M. Molina, J. Aguillón, B. Pesce, 2013, Arthritis and rheumatism.

Dexamethasone Preconditioning Improves the Response of Collagen-Induced Arthritis to Treatment with Short-Term Lipopolysaccharide-Stimulated Collagen-Loaded Dendritic Cells

J. Aguillón, O. Aravena, D. Catalán, 2013, Clinical & developmental immunology.

Dexamethasone and Monophosphoryl Lipid A Induce a Distinctive Profile on Monocyte-Derived Dendritic Cells through Transcriptional Modulation of Genes Associated With Essential Processes of the Immune Response

Ahmed M. Mehdi, M. Molina, J. Aguillón, 2017, Front. Immunol..

Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis

J. Aguillón, E. James, M. Carrascal, 2022, Annals of the Rheumatic Diseases.

Immunosuppressive Mechanisms of Regulatory B Cells

J. Aguillón, O. Aravena, D. Catalán, 2021, Frontiers in Immunology.

Regulatory B cells: Development, phenotypes, functions, and role in transplantation

R. Lechler, G. Lombardi, E. Nova-Lamperti, 2019, Immunological reviews.

Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?

J. Aguillón, C. Llanos, A. Cruzat, 2006, Immunobiology.

Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets.

M. Molina, J. Aguillón, B. Pesce, 2011, Immunobiology.

Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation

A. Biere, J. Aguillón, O. Aravena, 2015, Front. Immunol..

B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy

J. Aguillón, A. Kalergis, O. Aravena, 2010, Arthritis research & therapy.

The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism

J. Aguillón, L. Salazar, H. Gatica, 2011, Clinical Rheumatology.

Weak CD4+ T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles

A. Escobar, J. Aguillón, O. Aravena, 2012, Rheumatology International.